Lonza Amaxa 4D-Nucleofector system
The Amaxa Nucleofector technology is claimed to be the first efficient non-viral transfection method for primary cells and hard-to-transfect cell lines.
With a new platform, the 4D-Nucleofector system enables nucleofection of cells in several formats, combined with good performance and convenience.
Its features include: transfection of variable cell numbers with same conditions; choice of throughputs from 1 to 16 wells in just 10 s; nucleofection of adherent cells for functional assays at various cellular stages.
The modular system will accommodate upcoming transfection challenges and a current transfection protocol database is available with 690 cells listed, which is continuously updated.
Phone: 1300 657508
Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry
The range provides users with more options when designing spectral flow cytometry panels,...
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...